The First Case of 4H Syndrome with Type 1 Diabetes Mellitus

G��n��l B��y��ky��lmaz, B����ra Erozan ��avdarl��, Keziban Toksoy Ad��g��zel, Mehmet Ad��g��zel, ��i��dem Seher Kasapkara, Fatih G��rb��z, Mehmet Boyraz, Esra G��rka��
Author Information
  1. G��n��l B��y��ky��lmaz: Ankara Bilkent City Hospital, Clinic of Pediatric Endocrinology, Ankara, T��rkiye ORCID
  2. B����ra Erozan ��avdarl��: Ankara Bilkent City Hospital, Clinic of Medical Genetics, Ankara, T��rkiye ORCID
  3. Keziban Toksoy Ad��g��zel: Ankara Bilkent City Hospital, Clinic of Pediatric Endocrinology, Ankara, T��rkiye ORCID
  4. Mehmet Ad��g��zel: Ankara University Faculty of Medicine, Department of Radiology, Ankara, T��rkiye ORCID
  5. ��i��dem Seher Kasapkara: Ankara Y��ld��r��m Beyaz��t University Faculty of Medicine, Department of Pediatric Metabolism and Nutrition, Ankara, T��rkiye ORCID
  6. Fatih G��rb��z: Ankara Y��ld��r��m Beyaz��t University Faculty of Medicine, Department of Pediatric Endocrinology, Ankara, T��rkiye ORCID
  7. Mehmet Boyraz: Ankara Y��ld��r��m Beyaz��t University Faculty of Medicine, Department of Pediatric Endocrinology, Ankara, T��rkiye ORCID
  8. Esra G��rka��: Ankara Y��ld��r��m Beyaz��t University Faculty of Medicine, Department of Pediatric Neurology, Ankara, T��rkiye ORCID

Abstract

4H syndrome is a rare, progressive, hypomyelinating leukodystrophy. Hypomyelination, hypodontia, and hypogonadotropic hypogonadism are the three classic features of 4H syndrome. Biallelic pathogenic variants in , and gene cause 4H leukodystrophy. Herein, we present clinical features in two siblings with 4H syndrome. The first patient (16 years) presented with hypogonadotropic hypogonadism, euthyroid Hashimoto���s thyroiditis and type 1 diabetes mellitus (DM). The second patient (13.5 years) showed normal physical, biochemical and hormonal examination at presentation. The second patient was followed up for epilepsy between the ages of 6 months and 6 years, when his epilepsy medication was discontinued, and he did not have seizure again. T2-weighted magnetic resonance images showed increased signal intensity secondary to Hypomyelination in both. They were subsequently found to have a homozygous variant in the POLR3A gene. 4H syndrome may present with neurological and non-neurological findings in addition to classic features of 4H syndrome. Progressive neurological deterioration may occur and endocrine dysfunction may be progressive. Although multiple endocrine abnormalities associated with this disorder have been reported to date, a case accompanied by type 1 DM has not previously been published. We do not know if this was a coincidence or an expansion of the phenotype. However, reporting such cases helps to determine the appropriate genotype-phenotype correlation in patients.

Keywords

References

  1. Neurol Genet. 2018 Dec 03;4(6):e289 [PMID: 30584594]
  2. Neurology. 2006 Dec 12;67(11):2066-9 [PMID: 17159124]
  3. J Clin Endocrinol Metab. 2021 Jan 23;106(2):e660-e674 [PMID: 33005949]
  4. Acta Neurol Belg. 2020 Dec;120(6):1461-1462 [PMID: 32052360]
  5. Pediatr Dent. 2010 Sep-Oct;32(5):386-92 [PMID: 21070704]
  6. Am J Hum Genet. 2011 Nov 11;89(5):644-51 [PMID: 22036171]
  7. Genet Med. 2015 May;17(5):405-24 [PMID: 25741868]
  8. Am J Med Genet A. 2020 Jul;182(7):1776-1779 [PMID: 32319736]
  9. Am J Hum Genet. 2011 Sep 9;89(3):415-23 [PMID: 21855841]
  10. Trends Genet. 2007 Dec;23(12):614-22 [PMID: 17977614]
  11. Brain. 2010 Oct;133(10):2971-82 [PMID: 20881161]
  12. J Child Neurol. 2014 Feb;29(2):214-20 [PMID: 24105487]
  13. Expert Rev Neurother. 2020 Jan;20(1):65-84 [PMID: 31829048]
  14. Acta Neuropathol. 2017 Sep;134(3):351-382 [PMID: 28638987]
  15. Neurology. 2014 Nov 18;83(21):1898-905 [PMID: 25339210]
  16. Front Mol Biosci. 2021 Jul 30;8:696438 [PMID: 34395528]
  17. Hum Mol Genet. 2016 Oct 1;25(19):4302-4314 [PMID: 27506977]
  18. CNS Neurosci Ther. 2022 Mar;28(3):458-460 [PMID: 34953043]
  19. J Neurol Sci. 2011 Jan 15;300(1-2):179-81 [PMID: 20884016]

MeSH Term

Humans
Diabetes Mellitus, Type 1
Male
Adolescent
Hypogonadism
RNA Polymerase III
Anodontia
Hereditary Central Nervous System Demyelinating Diseases

Chemicals

RNA Polymerase III
POLR3A protein, human

Word Cloud

Created with Highcharts 10.0.04Hsyndrome1leukodystrophyhypogonadotropichypogonadismfeaturespatientyearstypemayprogressiveclassicgenepresentdiabetesmellitusDMsecondshowedepilepsy6POLR3AneurologicalendocrinerarehypomyelinatingHypomyelinationhypodontiathreeBiallelicpathogenicvariantscauseHereinclinicaltwosiblingsfirst16presentedeuthyroidHashimoto���sthyroiditis135normalphysicalbiochemicalhormonalexaminationpresentationfollowedagesmonthsmedicationdiscontinuedseizureT2-weightedmagneticresonanceimagesincreasedsignalintensitysecondaryhypomyelinationsubsequentlyfoundhomozygousvariantnon-neurologicalfindingsadditionProgressivedeteriorationoccurdysfunctionAlthoughmultipleabnormalitiesassociateddisorderreporteddatecaseaccompaniedpreviouslypublishedknowcoincidenceexpansionphenotypeHoweverreportingcaseshelpsdetermineappropriategenotype-phenotypecorrelationpatientsFirstCaseSyndromeTypeDiabetesMellitus4H

Similar Articles

Cited By (1)